EMBalance aims to develop a Decision Support System i.e. a computer-based information system that will
support clinical decision-making, towards accurate and early
diagnosis and efficient treatment
planning of balance disorders. The
project’s objective is to collect balance related data from clinical and non
clinical domains, and by using mathematics and computation tools to evaluate,
harness, combine and extend existing
theoretical balance models,i n order to produce a Hypermodel that is patient-specific and which accurately
simulates the complex physiological system of balance at more than one
biological scales. During the project, the computer based intelligent system will
be provided and “trained” with a multitude of existing clinical data (e.g.,
patient symptoms and clinical test
results of actual patients) as well as non-clinical data (e.g., the dimensions
and orientation of the balance sensor organs and related abnormalities). Human
Computer Interaction techniques will inform the development of computer to user
interfaces to make this system user-friendly, efficient and intuitive. The
system will be made available via web-services to ensure that is both widely
accessible and accepted. Small scale clinical trials will be conducted during
the second and third year of the project for the clinical validation of the
project outcomes in terms of balance disorders diagnosis and treatment.
EMBalance provides, also, an efficient validation of the developed platform and an analytical clinical proof of concept of the EMBalance knowledge based Decision Support System (DSS) that will secure the wide acceptance of the final platform by the healthcare community that cares for balance disorders patients. The validation targets will increase diagnostic accuracy and clinical effectiveness and will refine the EMBalance system, thus ensuring, clinicians’ confidence in the DSS and foremost, patients’ wellbeing and safety. Towards this aim and long-term vision of the project, the validation will be extended to aerospace data obtained from cosmonauts at different moments before spaceflight and after their return from space.
Page last modified on 28 jan 14 08:47
Funded by the European Union.